Astera Labs, Inc. (ALAB) Stock Forecast
ALAB analyst forecast
as of October 18, 2026- Analyst consensus
- Buy 4.12 / 5 from 26 analysts
- Price target
- $391.77 average of analyst targets
- Upside to target
- +37.1% from the latest close
- Next earnings
- November 3, 2026 EPS estimate $0.83
- 52-week range
- $100.27 – $483.02
ALAB analyst ratings
26 analystsNumber of analysts at each rating.
ALAB price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
ALAB earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $1.19 | $1.18 | $1.21 | $0.49 | +143.3% | 20 |
| Current fiscal year (2026) | $4.03 | $3.90 | $4.33 | $1.84 | +119.2% | 21 |
| Next fiscal year (2027) | $6.40 | $4.35 | $8.80 | $4.03 | +58.7% | 23 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
ALAB revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $550.8M | $545.7M | $557.0M | +138.9% | 18 |
| Current fiscal year (2026) | $1.91B | $1.86B | $1.99B | +123.9% | 21 |
| Next fiscal year (2027) | $2.98B | $2.19B | $3.68B | +55.9% | 24 |
ALAB EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
ALAB revenue: reported and forecast
ALAB EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0.79 | $1.19 | $1.19 | $1.19 | $1.19 | +51.1% | 19 up · 0 down |
| Current fiscal year (2026) | $3.01 | $4.03 | $4.03 | $4.03 | $4.03 | +33.9% | 21 up · 0 down |
| Next fiscal year (2027) | $4.37 | $6.39 | $6.39 | $6.39 | $6.40 | +46.6% | 20 up · 0 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
ALAB earnings surprises
Reported EPS vs the consensus estimate for the last 11 quarters; ALAB beat in 11 of 11.
What analysts expect from ALAB
26 analysts cover Astera Labs; their consensus rating is buy (4.12 on a 1–5 scale, where 5 is a strong buy). The average price target is $391.77, 37.1% above the latest close of $285.82. Analysts expect earnings of $4.03 per share for 2026, +119.2% from a year earlier. For 2027 the average estimate is $6.40 per share on revenue of $3.0 billion. Astera Labs beat the EPS estimate in 11 of the last 11 quarters.
Related: ALAB income statement, ALAB key metrics, ALAB chart. See the ALAB stock overview for the latest quote and news.
ALAB forecast FAQ
What is Astera Labs's price target?
The average analyst price target for Astera Labs is $391.77, 37.1% above the latest close of $285.82.
Is Astera Labs a buy, hold or sell?
Of 26 analysts covering Astera Labs, 11 rate it a strong buy, 7 a buy, 8 a hold, 0 a sell and 0 a strong sell, a consensus of buy. Ratings are opinions, not a recommendation from Quotelinks.
What is Astera Labs's EPS forecast?
Analysts forecast $4.03 per share for 2026 (range $3.90 to $4.33); for 2027 the estimate is $6.40.
What is Astera Labs's revenue forecast?
The average revenue estimate for 2026 is $1.9 billion, growth of 123.9%; for 2027 it is $3.0 billion.
When does Astera Labs report earnings?
Astera Labs is expected to report results for the quarter ending September 30, 2026 on November 3, 2026 after the market closes; the EPS estimate is $0.83.
Does Astera Labs usually beat earnings estimates?
Astera Labs reported EPS at or above the analyst estimate in 11 of the last 11 quarters.